178 related articles for article (PubMed ID: 15335423)
1. Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors.
Peles E; Lidar Z; Simon AJ; Grossman R; Nass D; Ram Z
Neurosurgery; 2004 Sep; 55(3):562-7; discussion 567-8. PubMed ID: 15335423
[TBL] [Abstract][Full Text] [Related]
2. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in children with brain tumors.
Sobol-Milejska G; Mizia-Malarz A; Musiol K; Chudek J; Bożentowicz-Wikarek M; Wos H; Mandera M
Adv Clin Exp Med; 2017 Jul; 26(4):571-575. PubMed ID: 28691414
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors.
Gupta K; Radotra BD; Banerjee AK; Nijhawan R
Anal Quant Cytol Histol; 2004 Aug; 26(4):223-9. PubMed ID: 15457675
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma.
Sampath P; Weaver CE; Sungarian A; Cortez S; Alderson L; Stopa EG
Cancer Control; 2004; 11(3):174-80. PubMed ID: 15153841
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study.
Vera S; Sinning M; Vergara M; Lemus D; Rosas C
J Neurooncol; 2019 Nov; 145(2):233-239. PubMed ID: 31624989
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of tissue endostatin in human malignant gliomas.
Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Ugurel S; Rappl G; Tilgen W; Reinhold U
J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
[TBL] [Abstract][Full Text] [Related]
10. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
[TBL] [Abstract][Full Text] [Related]
11. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
[TBL] [Abstract][Full Text] [Related]
12. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?
Weindel K; Moringlane JR; Marmé D; Weich HA
Neurosurgery; 1994 Sep; 35(3):439-48; discussion 448-9. PubMed ID: 7528359
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic protein expression in advanced epithelial ovarian cancer.
Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?
Oehring RD; Miletic M; Valter MM; Pietsch T; Neumann J; Fimmers R; Schlegel U
J Neurooncol; 1999; 45(2):117-25. PubMed ID: 10778727
[TBL] [Abstract][Full Text] [Related]
15. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic potential of the cerebrospinal fluid (CSF) of patients with high-grade gliomas measured with the chick embryo chorioallantoic membrane assay (CAM).
Sinning M; Letelier R; Rosas C; Fuenzalida M; Lemus D
Biol Res; 2012; 45(2):135-8. PubMed ID: 23096357
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.
Bredel M; Pollack IF; Campbell JW; Hamilton RL
Clin Cancer Res; 1997 Nov; 3(11):2157-64. PubMed ID: 9815610
[TBL] [Abstract][Full Text] [Related]
19. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
Greenfield JP; Jin DK; Young LM; Christos PJ; Abrey L; Rafii S; Gutin PH
Neurosurgery; 2009 May; 64(5):819-26; discussion 826-7. PubMed ID: 19404145
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of vessels with smooth muscle layer in astrocytic tumors: correlation with histological grade and prognostic significance.
Sato S; Sato Y; Hatakeyama K; Marutsuka K; Yamashita A; Takeshima H; Asada Y
Histol Histopathol; 2011 Apr; 26(4):497-504. PubMed ID: 21360443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
